Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4262]

Why some cancers may respond poorly to key drugs discovered

Why some cancers may respond poorly to key drugs discovered

Black women may be less likely to receive timely treatment for breast cancer

Black women may be less likely to receive timely treatment for breast cancer

ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early breast cancer

ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early breast cancer

ESMO 2020: First-time data revealed from two studies evaluating pembrolizumab plus lenvatinib in seven different tumour types

ESMO 2020: First-time data revealed from two studies evaluating pembrolizumab plus lenvatinib in seven different...

ESMO 2020: Sacituzumab govitecan-hziy extends survival in phase 3 ASCENT study of metastatic triple-negative breast cancer

ESMO 2020: Sacituzumab govitecan-hziy extends survival in phase 3 ASCENT study of metastatic triple-negative...

Algorithms uncover cancers' hidden genetic losses and gains

Algorithms uncover cancers' hidden genetic losses and gains

Spotting breast cancer's spread to the brain before symptoms start could improve survival

Spotting breast cancer's spread to the brain before symptoms start could improve survival

Combining two precision medicines can treat drug-resistant cancers

Combining two precision medicines can treat drug-resistant cancers

Major trial uses blood test to match women with breast cancer to precision treatments

Major trial uses blood test to match women with breast cancer to precision treatments

Major trial uses blood test to match women with breast cancer to range of precision treatments

Major trial uses blood test to match women with breast cancer to range of precision treatments

More from ecancer